Baxter International Inc.

Baxter International Inc. announced today that it has begun, patients with malignant solid tumors in a Phase I clinical trial of a monoclonal antibody, which the company’s efforts, its oncology portfolio with advanced biological research and development expand.

The discovered communication factor is a novel biological molecule presented Prof Engelberg – Kulka. It is a peptide , which is produced by the bacteria. The chemical characterization of the new communication factor was particularly difficult for the researchers because of two main reasons: It is in the bacterial culture in minute amounts, and the factor decomposes under the conditions that during standard during standard chemical methods for characterization. It was therefore necessary new new specific method. Research has even several bacterial identified identified involved in the generation of the communication factor, said Prof. Engelberg – Kulka.Main author Eric Finkelstein, William H at the Duke Global Health Institute as well as as Director Healthcare Services Research Program at Duke – NUS Graduate Medical School in Singapore summarizes degree states that:.

‘If these forecasts prove to be correct, the adverse health and inexpensive consequences of obesity have continue further without significant operations. ‘.